New York State Common Retirement Fund
XENE icon

New York State Common Retirement Fund’s Xenon Pharmaceuticals XENE Stock Holding History

New York State Common Retirement Fund’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.7M Buy
210,471
+21,966
+12% +$1.22M 0.02% 668
2026
Q1 		$11M Buy
188,505
+1,800
+1% +$82.9K 0.02% 680
2025
Q4 		$8.37M Buy
186,705
+14,997
+9% +$630K 0.01% 813
2025
Q3 		$6.89M Buy
171,708
+5,236
+3% +$184K 0.01% 927
2025
Q2 		$5.21M Buy
166,472
+24,100
+17% +$786K 0.01% 1053
2025
Q1 		$4.78M Buy
142,372
+9,851
+7% +$374K 0.01% 1074
2024
Q4 		$5.19M Hold
132,521
– – 0.01% 1091
2024
Q3 		$5.22M Sell
132,521
-18,319
-12% -$739K 0.01% 1083
2024
Q2 		$5.88M Sell
150,840
-41,912
-22% -$1.68M 0.01% 1050
2024
Q1 		$8.3M Buy
192,752
+2,440
+1% +$112K 0.01% 896
2023
Q4 		$8.77M Buy
190,312
+5,680
+3% +$201K 0.01% 892
2023
Q3 		$6.31M Buy
184,632
+1
+0% +$37 0.01% 1014
2023
Q2 		$7.11M Buy
184,631
+164,952
+838% +$6.56M 0.01% 1021
2023
Q1 		$704K Buy
19,679
+3,029
+18% +$112K ﹤0.01% 2002
2022
Q4 		$657K Buy
16,650
+650
+4% +$23.7K ﹤0.01% 2185
2022
Q3 		$578K Hold
16,000
– – ﹤0.01% 2267
2022
Q2 		$487K Buy
16,000
+4,500
+39% +$136K ﹤0.01% 2378
2022
Q1 		$352K Buy
11,500
+3,400
+42% +$102K ﹤0.01% 2565
2021
Q4 		$253K Buy
+8,100
New +$242K ﹤0.01% 2781

Other funds holding XENE

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

New York State Common Retirement Fund's XENE Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Xenon Pharmaceuticals (XENE) stake by 12% in Q2 2026, buying an estimated $1.22M and bringing the position to 210,471 shares worth $12.7M. The position accounts for 0.02% of the portfolio, ranked #668.

New York State Common Retirement Fund first reported a position in XENE in Q4 2021 and has held it in 19 quarters since. 60 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

  • New York State Common Retirement Fund held 210,471 shares of Xenon Pharmaceuticals worth $12.7M as of Q2 2026.
  • New York State Common Retirement Fund bought 21,966 Xenon Pharmaceuticals shares in Q2 2026, an estimated $1.22M.
  • Xenon Pharmaceuticals made up 0.02% of New York State Common Retirement Fund's portfolio in Q2 2026, its #668 holding.
  • New York State Common Retirement Fund first reported a position in Xenon Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • 60 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.